Much - possibly even too much - has been published about chemosensory dysfunction as a consequence of COVID-19. Studies have reported prevalence of taste loss in up to 89.9% (1), which is in a similar range as COVID-19 related smell loss. However, most of these publications rely solely on patients' self-reports. Only few studies used validated psychophysical tests to specifically address olfaction and gustation. Especially for gustation, it is evident that subjective reporting does not correlate well with more objective psychophysical findings, often leading to an overestimation of subjectively impaired taste.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- risk factors
- ejection fraction
- newly diagnosed
- chronic kidney disease
- adverse drug
- respiratory syndrome coronavirus
- oxidative stress
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- systematic review
- physical activity
- patient reported outcomes
- meta analyses
- drug induced